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Abstract
In this study, the pathogenic behavior of PRRSV 13V091 and 13V117, isolated in 2013 from two different Belgian
farms with enzootic respiratory problems shortly after weaning in the nursery, were compared with the Belgian
strain 07V063 isolated in 2007. Full-length genome sequencing was performed to identify their origin. Twelve
weeks-old pigs were inoculated intranasally (IN) with 13V091, 13V117 or 07V063 (9 pigs/group). At 10 days post
inoculation (dpi), 4 animals from each group were euthanized and tissues were collected for pathology, virological
and serological analysis. 13V091 infection resulted in the highest respiratory disease scores and longest period of
fever. Gross lung lesions were more pronounced for 13V091 (13%), than for 13V117 (7%) and 07V063 (11%). The
nasal shedding and viremia was also most extensive with 13V091. The 13V091 group showed the highest virus
replication in conchae, tonsils and retropharyngeal lymph nodes. 13V117 infection resulted in the lowest virus
replication in lymphoid tissues. 13V091 showed higher numbers of sialoadhesin− infected cells/mm2 in conchae,
tonsils and spleen than 13V117 and 07V063. Neutralizing antibody response with 07V063 was stronger than with
13V091 and 13V117. It can be concluded that (i) 13V091 is a highly pathogenic type 1 subtype 1 PRRSV strain that
replicates better than 07V063 and 13V117 and has a strong tropism for sialoadhesin− cells and (ii) despite the close
genetic relationship between 13V117 and 07V063, 13V117 has an increased nasal replication and shedding, but a
decreased replication in lymphoid tissues compared to 07V063.
Introduction
Porcine reproductive and respiratory syndrome (PRRS)
is a devastating disease that continuously hits swine in-
dustry all over the world [1]. A recent economic analysis
in the US demonstrated that the amount of total annual
losses increased from $560 million in 2005 to $664
million in 2011 [2]. The disease first appeared in the US
in the late eighties and then a few years later in Europe
and Asia [3]. The causative agent is a positive single-
stranded enveloped RNA virus classified together with
lactate dehydrogenase virus (LDV), simian hemorrhagic
fever virus (SDHF) and equine arteritis virus (EAV) in
the family of the Arteriviridae within the order of the
Nidovirales [4]. PRRSV causes reproductive failure in
late-term gestation sows with an increased number of
stillborn, mummified and weak-born piglets. Respiratory
disorders are characterized mainly by dyspnea and tach-
ypnea in young animals [5,6].
The PRRSV genome is approximately 15 kb in length
and contains nine open reading frames (ORFs) [3]. Open
reading frames 1a and 1b constitute 75% of the viral
genome and encode viral replicase polyproteins, which
are processed by self-encoded proteases into 14 non-
structural proteins (nsp) [3]. Major (GP5, M, N) and
minor (GP2, GP3, GP4, ORF5a-protein, E) structural
proteins are being encoded at the 3’ end of the genome
by ORFs 2a, 2b, 3, 4, 5, 5a, 6 and 7 [7]. Like with other
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nidoviruses, transcription of the PRRSV genome is char-
acterized by the formation of a 3’-co-terminal nested set
of subgenomic messenger RNAs, each of them with a
common 5’-leader sequence [8].
Two distinct genotypes were identified, and designated
as European type 1 (prototype LV-Lelystad, GenBank:
M96262) and American type 2 (prototype VR2332, Gen-
Bank: AY150564), with 40% differences at the nucleotide
level [7]. A large genetic variability has been shown
within both subtypes [9]. Genetic heterogeneity is one of
the main reasons why current commercial attenuated
and inactivated vaccines provide incomplete protection
against heterologous strains and as a result there is an
urgent need for a novel generation of vaccines [10,11].
Starting from 2006, new highly pathogenic strains emerged,
causing large-scale outbreaks in Eastern Europe (type 1,
prototype Lena, GenBank: JF802085), and Southeastern
Asia (type 2, prototype JXA1, GenBank: EF112445). These
isolates are characterized by high viral loads in blood and
tissues, high fever, severe general clinical signs and in-
creased mortality [12-14]. A common genetic characteris-
tic of highly pathogenic strains of both PRRSV type 1 and
2 is a discontinuous 30-amino acid deletion in the non-
structural protein 2 (nsp2) (Lena: aa 710–739, JXA1: aa
534–563) [13,14]. However, this deletion is most probably
not solely responsible for differences in virulence, as nsp2
is the most divergent one in PRRSV [7]. In Europe, highly
virulent strains from Eastern Europe clearly differed from
the circulating low virulent Western European strains and
taxonomically they were designated as different type 1
subtypes (LV-like strains: subtype 1, Lena-like strains: sub-
type 3) [4]. Subtype 3 strains are constrained in Eastern
Europe and up till now, there were no reports of highly
pathogenic strains emerging in Western Europe [4].
In the present study, the virulence and pathogenicity
of three PRRSV strains from Belgium were evaluated:
two isolates (13V091 and 13V117) from 2013, originat-
ing from farms experiencing uncommon long-lasting
anorexia, fever and respiratory problems within the first
two weeks after weaning during an enzootic PRRSV in-
fection, and the well-characterized Belgian strain 07V063
(GenBank: GU737264) from 2007 that was used as a refer-
ence [15,16]. Full-length genome sequencing was per-
formed to characterize these PRRSV isolates.
Materials and methods
Viruses
PRRSV 13V091 and 13V117 were isolated from sera
of pigs that showed severe respiratory problems in two
Belgian farms. Virus isolation was performed as de-
scribed before [12]. Briefly, porcine alveolar macro-
phages (PAM) were cultured in RPMI 1640 + GlutaMax
modified medium (Gibco Invitrogen), supplemented
with 10% fetal calf serum (FCS), 1% non-essential amino
acids (Gibco Invitrogen), 1 mM sodium pyruvate and a
mixture of antibiotics. Subsequently, cells were inoculated
with ten-fold serial dilutions of sera and when cytopathic
effect (CPE) was observed after three days, cells were fixed
and stained with immunohistochemistry (IPMA) [10]. The
monoclonal antibody (mAb) 13E2 against the nucleocapsid
protein of PRRSV was used as primary antibody to identify
PRRSV [17]. After isolation, 13V091 and 13V117 were
grown in PAM and used for sequencing and pathogenesis
studies. The viral stocks were confirmed to be free from
Mycoplasma, porcine parvovirus, porcine circoviruses and
swine influenza viruses. The 07V063 strain was enclosed
as a reference. A 2nd-3rd passage of 13V117, 13V091 and
07V063 was used for the animal inoculations.
Experimental design
Thirty-six twelve-week-old pigs, originating from a PRRSV-
negative farm, were randomly divided in 4 groups of 9
animals. Relevant pathogens (PRRSV, SIV, PCV2) were not
detected in the animals. Experiments were conducted in a
biosafety level 2 (BSL-2) facility and were approved by the
Ethical Committee of the University of Ghent (EC 2010/
090). The pigs of groups 13V091, 13V117 and 07V063
were inoculated intranasally (IN) with 2 mL containing 105
tissue culture infectious dose with 50% end point (TCID50)
of the respective viruses (1 mL per nostril). Group CON
consisted of animals mock-inoculated with PBS. Rectal
temperature and clinical observations were monitored
daily, starting from the third day before challenge until the
21st day post inoculation (dpi). Body temperature over
40.0 °C was considered as fever. The scoring system was
used before and is fully described in previous studies
[12,14]. Breathing, sneezing, coughing, nasal discharge, live-
liness, ear discoloration, presence of peri-ocular oedema
and diarrhea were taken into account. Detailed list and pa-
rameters of the clinical scores is shown in Additional file 1.
In all groups, blood samples and nasal swabs were taken at
0, 3, 5, 7, 10, 14, 21, 28, 35 and 42 dpi. Plasma and nasal se-
cretions were collected and stored at −70 °C for virus titra-
tion. At 10 dpi, 4 pigs from each group were euthanized
and two samples were collected from the following tissues:
nasal mucosa (septum and conchae), pharynx, tonsils,
lymph nodes (pharyngeal, bronchial, mediastinal, inguinal),
lungs (apical, cardiac and diaphragmatic lobes from both
sides) and spleen. Lungs were examined macroscopically.
One sample was embedded in methocel and was snap fro-
zen for double immunofluorescense (IF) stainings, and the
second sample was stored at −70 °C for virus titration.
Gross pathology and bacteriology
After euthanasia, individual lungs were collected, and to
all lung lobes macroscopic lesions were given a score to
estimate the percentage of lungs affected by pneumonia
using the evaluation system adapted from Halbur et al. [18].
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Samples from lungs (cardiac left) and lymph nodes (bronchial)
were collected after euthanasia and bacteriological
analysis was performed. Each sample was inoculated
on Columbia agar or Columbia CAN agar supplemented
with 5% sheep blood (Oxoid, Hampshire, UK) with a
Staphylococcus pseudintermedius streak for the growth
support of NAD-dependent bacteria (Actinobacillus, Hae-
mophilus spp.). Plates were incubated for 48 h in a 5%
CO2-enriched environment at 35 ± 2 °C and phenotypic
identification of isolated bacteria was performed as earlier
described [19].
Virus titration
Nasal secretions and 20% suspensions of the collected tis-
sues were titrated on PAM as previously described [10].
Nasal swabs were collected using Aluminium Rayon ster-
ile plain swabs (160C, Copan Italia S.p.A., Italy). After
swabbing, the swabs were brought into transportation
medium consisting of phosphate buffer saline (PBS),
10% fetal calf serum (FCS) and a mixture of antibiotics.
Afterwards, the swabs were vortexed, and the diluted
secretions were titrated [12]. Tissue suspensions were
titrated on PAM in quadruplicate and a final TCID50
was determined after subjecting the cells to a PRRSV-
specific immunoperoxidase staining to analyze the pres-
ence of PRRSV-positive cells.
Serology
Serum samples were examined for the presence of
PRRSV-specific antibodies using IPMA plates as de-
scribed before [10]. In these plates, LV-infected MARC-
145 cells were used to detect PRRSV-specific antibodies.
Virus neutralizing antibody titers were detected with a
seroneutralization (SN) test on MARC-145 cells after
propagation of PRRSV strains on this cell line. Two fold
dilution series of sera were made and an equal volume
containing 100 TCID50 PRRSV of the homologous
strains was added to each dilution and the mixture was
further incubated for 1 h at 37 °C. Afterwards, the
serum-virus mixture was transferred to suspension cul-
tures of MARC-145 cells and the cells were analyzed for
cytopathic effect (CPE) at ten days post inoculation. The
virus neutralizing antibody titers were determined as the
reciprocal of the highest dilution that inhibited CPE in
50% of the wells [16]. Samples that tested negative in
IPMA were given a numerical value of 1.7 and in SN test
a numerical value of 0.5.
Quantification and identification of PRRSV-positive cells
To quantify and identify viral antigen and sialoadhesin
(Sn) positive cells in the different tissues, several 9 μm
cryosections were made at a distance of 50 μm between
each other and fixed in 100% methanol at −20 °C for
15 min. Mouse monoclonal antibodies were used against
the PRRSV N protein (13E2, 1:25, IgG2a) and porcine
sialoadhesin (41D3, 1:2, IgG1) [18]. Isotype-specific sec-
ondary antibodies conjugated with FITC and Alexa Fluor
594 (1:500, Invitrogen) were used to reveal the different
antigens. Cell nuclei were stained with Hoechst 33342
(Invitrogen) and to confirm the specificity of each anti-
body, negative isotype-specific control monoclonal anti-
bodies were used: 13D12 against gD of PRV (IgG1), and
1C11 against gB of PrV (IgG2a) [20]. Countings were
made in 5 sections with 5 fields per section measured in
a blind way. Results were expressed per mm2, and ana-
lysis was performed using a Leica TCS SPE laser-
scanning confocal microscope (Leica Microsystems
GmbH, Wetzlar, Germany).
Sequencing
Total RNA was extracted from 140 μL PAM culture
supernatant of a 2nd passage of 13V091 and a 3rd pas-
sage of 13V117 strain using the QIAcube 230 volt robot
and the QIAamp® Viral RNA Mini kit (QIAGEN, cat.
No. 52906). The QIAamp Viral RNA body fluid standard
program was used as the extraction protocol with the
elution volume of 60 μL. The RNA was screened for
PRRSV using the previously published Kleiboeker modi-
fied type 1 assay [21]. PCR products covering the whole
PRRSV genome in two fragments were produced from
full genome cDNA as described elsewhere [22]. The
PCR fragments for each virus were pooled in equimolar
concentration (165 ng in total) and sequenced by the
Ion Torrent PGM sequencer using the 318v2 chip
(DMAC, Technical University of Denmark). After initial
removal of adaptors and low quality sequences, the quality
of the output data (FastQ) files was examined using the
applicant FastQC (v. 0.10.1). The reads were trimmed ac-
cordingly to the FastQC report. De novo assembly was
performed using the commercial software CLC Genomics
v. 4.6.1 (CLCBIO, Aarhus, Denmark) and the genetic com-
parability of the obtained contigs was found using the
NCBI’s Basic Local Alignment Search Tool (BLASTn).
The most similar sequence to the newly sequenced virus
found by NCBI BLASTn was used as reference sequence
for mapping reads to a reference. The final consensus se-
quence was found by alignment of contigs derived from
de novo assembly and the sequence obtained from map-
ping to a reference. The consensus sequence from each
virus was aligned to other publicly available full genome
PRRS type 1 viruses using MUSCLE (Multiple Sequence
Comparison by Log-Expectation). Gaps were either con-
firmed or closed by specifically designed primers sur-
rounding the gaps and sequenced by cycle sequencing
(LGC Genomics GmbH, Germany). All alignments and
phylogenetic analysis, were performed by the commercial
software CLC DNA workbench v. 6.9 (CLCBIO, Aarhus,
Denmark). The phylogenetic trees were constructed using
Frydas et al. Veterinary Research  (2015) 46:37 Page 3 of 17
the Neighbor Joining algorithm, nucleotide/protein dis-
tance measure: Kimura80/Kimura Protein model, and
Bootstrap analysis of 1000 replicates.
Statistics
All data were analyzed with GraphPad Prism 6 software
(GraphPad Software Inc., San Diego, CA, USA). Serological
titers (IPMA and SN) as well as viral loads were log-
transformed prior to the analyses. Gross pathology scores
and area under the curve (AUC) were analysed using
the non-parametric Kruskal-Wallis test with Dunn’s
post-test. Statistical analysis of continuous data was per-
formed using two-way analysis of variance (ANOVA) with
Tukey’s post-test. All results shown represent means and
standard deviation (SD). Results with P-values < 0.05 were
considered significantly different.
Results
Clinical signs and body temperature
Clinical scores in respiratory functions, liveliness and
presence of conjuctivitis are summarized in Figure 1.
Daily registration of clinical scores for each individual
animal is shown in Additional file 2. Animals from the
control group did not display clinical signs during the
whole study. The 13V091 group exhibited significantly
(P < 0.05) higher mean scores from 3 till 10 and at 14
dpi compared to the 13V117 group, and from 2 till 8
dpi compared to the 07V063 group. All 13V091-in-
fected animals scored positive for clinical signs at least
at one time point during the experiment. Respiratory
symptoms were observed from the beginning of the ex-
periment with a peak at 4 dpi (8 out of 9 animals) and
lasted until 15 dpi (1 out of 4 animals). The 13V117
group showed significantly (P < 0.05) higher mean scores
compared to the 07V063 group at 2 and 4 dpi. Animals
scored positive from 2 till 6 dpi but not all the animals
showed respiratory disorders. A peak was observed at 4
dpi (4 out of 9 animals). In the 07V063 group, 2 animals
showed clinical scores from 2 till 4 dpi and from 7 till
11 dpi. Loss of appetite was not observed in any group
but visible growth retardation was marked in the
13V091 group compared to the other groups. Diarrhea
was also apparent in the 13V091 group between 13 and
21 dpi. Nasal discharge, coughing or ear discoloration
was never observed.
Body temperature data are represented for each group
in Figure 2. Detailed daily registration of body temperature
for each individual animal is presented in Additional file 2.
The mean body temperature of group 13V091 was signifi-
cantly higher (P < 0.05) from 3 till 7 and at 13 dpi com-
pared to the 13V117 group and from 3 till 5 dpi
compared to the 07V063 group. In the 13V091 group, 8
out of 9 animals showed fever at least at one day during
the experiment, whereas in the 13V117 and the 07V063
group, only 5 and 6 out of 9 animals showed fever, re-
spectively. AUC values of individual pigs were calculated,
and afterwards the AUC means per group were calculated
and compared. The mean AUC value of increased body
temperature with a threshold at 39.5 °C was significantly
(P < 0.05) higher in the 13V091 group (6.0 ± 4.2) com-
pared to the 13V117 (1.2 ± 1.3) and control groups (0.2 ±
1.3) but not to the 07V063 group (3.5 ± 3.4). 13V091-
infected animals showed the highest mean number of
fever days (5.1 ± 4.2 days) which was significantly different
Figure 1 Clinical scores in pigs inoculated with PRRSV 13V091, 13V117 and 07V063 are summarized. Lines represent the mean value
in each group. Letters denote significant statistical differences (P < 0.05) between viral strains (a: 13V091 and 13V117, b: 13V091 and 07V063,
c: 13V117 and 07V063).
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(P < 0.05) from the 13V117 group (1.1 ± 1.1 days) but not
from the 07V063 group (3.4 ± 3.3 days).
Gross pathology and bacteriology
At 10 dpi, four pigs per group were euthanized and
necropsied. Swollen pharyngeal, bronchial, mediastinal
and inguinal lymph nodes were observed in the 13V091
and 07V063 infected animals. 13V091 induced a pneu-
monia that was characterized by tissue consolidation,
haemorrhagic spots and multifocal red tanned lesions
in both sides (Figure 3A). 13V117-infected animals
showed also tissue consolidation and single spotted lesions
located mainly at the cardiac lobe. In 07V063-infected
pigs, tissue consolidation and multifocal bilateral red-
tanned lesions, concentrated mainly at the cranial and car-
diac lobes, were observed. No gross pulmonary lesions
were found in negative control pigs, and no pleuritis and
no Mycoplasma-related lesions were observed in all animals
of the experiment. 13V091-infected pigs showed the highest
mean percentage of lungs with gross lesions (12.9 ± 3.6%),
which was significantly higher (P < 0.05) than the 13V117
group (6.5 ± 1.4%) and the control group (4.7 ± 2.4%) but
was not different from the 07V063 group (11.3 ± 9.4%)
(Figure 3B). Finally, samples from the cranial left part of the
lungs and the bronchial lymph nodes of euthanized pigs
were sent for bacteriological analysis. No specific bacterial
pathogens were isolated.
Virological analysis
Titration of nasal swabs in the 13V091 group showed sig-
nificantly higher mean titers (P < 0.05) at 5 dpi compared
to the 13V117 group, and at 3 and 5 dpi compared to
the 07V063 group. Group 13V117 exhibited signifi-
cantly higher mean titers than group 07V063 at 3 and 5
dpi (Figure 4). The highest mean AUC value was ob-
served in the 13V091 group (16.9 ± 3.7), which was sig-
nificantly higher (P < 0.05) than the 13V117 (13.3 ± 4.3)
and the 07V063 group (8.2 ± 4.3). Virus was detected
for the first time at 3 dpi and two animals remained
positive up till 14 dpi for the 13V091 and 07V063 groups,
whereas in the 13V117 group one animal remained posi-
tive until 21 dpi. The 13V091 group showed the highest
mean duration of nasal shedding (5.8 ± 2.4 days), which
was not significantly different from the nasal shedding
duration of the 13V117 (5.4 ± 2.4 days) and 07V063
(3.3 ± 1.9 days) group.
Figure 2 Body temperature of pigs upon inoculation with PRRSV 13V091, 13V117 and 07V063. Temperature≥ 40 °C was considered as
fever. Lines represent the mean value in each group.
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Viremia was first detected at 3 dpi and lasted until 14
dpi for the 13V091 group. Two pigs in the 13V117 and
07V063 groups remained positive until the 35th and
28th dpi, respectively. The 13V091 group showed sig-
nificantly higher (P < 0.05) mean virus titers at 5 dpi
compared to the 13V117 group, and at 5 and 10 dpi
compared to the 07V063 group. The 13V117 group
exhibited significantly higher mean titers at 5 and 7
dpi compared to the 07V063 group (Figure 5). Control
animals did not show viremia during the experiment.
13V091 showed the highest duration (8.8 ± 1.9 days)
compared to 13V117 (8.1 ± 1.8 days) and 07V063
(6.9 ± 0.7 days). The average AUC value of the 13V091
(22.2 ± 9.3) and the 13V117 group (25.1 ± 8.4), were
slightly higher than that of the 07V063 group (18.7 ±
10.5) (P > 0.05).
Serology
PRRSV-specific antibodies were first detected with IPMA
in all PRRSV-infected groups as early as 7 dpi (Figure 6A).
The highest mean antibody titers ranged from 212.9 to
214.1 for all groups and were reached at 21–35 dpi. No sig-
nificant difference was observed between the infected
groups at any time point. Control animals remained sero-
negative during the whole experiment.
In 07V063-infected animals, homologous SN titers
appeared at 28 dpi in three out of five pigs, and reached
a maximum mean titer at 49 dpi (23) when all animals
were positive. In the 13V091 group, SN titers against
the homologous strain could be detected in three pigs at
28 dpi (21) and the titers remained at a similar level until
49 dpi when all the animals became positive and the
group showed a mean titer of 21.4 ± 20.4 (Figure 6B).
Figure 3 Lung compartment analysis of animals infected with different PRRSV strains and euthanized at 10 dpi. Representative gross
pulmonary lesions (A), mean macroscopic lesion scores (B) and virus titers in different lung compartments (C) are presented. CrL: Cranial Left,
CrR: Cranial Right, CaL: Cardiac Left, CaR: Cardiac Right, DiL: Diaphragmatic Left, DiR: Diaphragmatic Right. Whiskers denote the standard deviation
(SD) and P < 0.05 values represent statistically significant comparisons.
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13V117-infected animals did not show any SN titer
against the homologous strain until 42 dpi when one pig
out of five was positive (21). At 49 dpi, one additional
pig became positive (22).
PRRSV titers in different organs
Respiratory tract
Tissues from animals euthanized at 10 dpi were col-
lected for PRRSV titration. In the conchae, 13V091-
infected animals showed higher (P > 0.05) mean virus
titers (5.1 ± 0.9 log10TCID50/g) than 13V117 (3.8 ± 2.1
log10TCID50/g) and 07V063 infected animals (3.7 ± 2.2
log10TCID50/g) (Figure 7A). In the 13V091-infected ani-
mals, septum and pharynx displayed titers of 2.6 ± 1.2
and 3.5 ± 1.6 log10TCID50/g respectively, which were
slightly higher than the ones in the 13V117 group
(septum: 2.2 ± 1.3 log10TCID50/g, pharynx: 3.0 ± 1.4
log10TCID50/g) and the 07V063 group (septum: 1.2 ±
0.1 log10TCID50/g, pharynx: 3.3 ± 1.1 log10TCID50/g),
but not significantly different. Slightly higher titers for
the 13V091 group were found after titration of lung
compartments (Figure 3C), and values from all strains
ranged from 4.8 to 6.2 log10TCID50/g. Samples from the
pigs of the control group were negative for virus isolation.
Lymphoid tissues
Average viral titers in tonsils (5.7 ± 0.5 log10TCID50/g)
and retropharyngeal lymph nodes (RPLN) (5.2 ± 0.4
log10TCID50/g) in the 13V091 group, were significantly
higher (P < 0.05), than in the 13V117 group (tonsils:
4.0 ± 2.0 log10TCID50/g, RPLN: 3.0 ± 1.8 log10TCID50/g),
but not from the 07V063 group (tonsils: 4.8 ± 1.0
log10TCID50/g, RPLN: 4.5 ± 2.0 log10TCID50/g). Virus ti-
tration of bronchial (BLN), mediastinal (MLN) and in-
guinal (ILN) lymph nodes of the 13V091 (BLN: 3.8 ±
0.4 log10TCID50/g, MLN: 4.4 ± 0.7 log10TCID50/g, ILN:
4.4 ± 0.8 log10TCID50/g) and 07V063 groups (BLN:
4.5 ± 0.8 log10TCID50/g, MLN: 3.4 ± 0.8 log10TCID50/g,
ILN: 4.2 ± 0.1 log10TCID50/g), showed significantly (P < 0.05)
higher titers compared to the 13V117 group (BLN: 1.6 ±
0.5 log10TCID50/g, MLN: 1.7 ± 0.5 log10TCID50/g, ILN:
2.5 ± 0.7 log10TCID50/g) (Figure 7C). Finally, in spleen, the
Figure 4 Virus titers in nasal secretions of pigs inoculated with PRRSV 13V091, 13V117 and 07V063. Lines represent the mean value in
each group. Whiskers denote the standard deviation (SD). The dotted line gives the detection limit for virus titration. Letters denote significant
statistical differences (P < 0.05) between viral strains (a: 13V091 and 13V117, b: 13V091 and 07V063, c: 13V117 and 07V063).
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Figure 5 Viremia in pigs inoculated with PRRSV 13V091, 13V117 and 07V063. Patterns represent individual animals. Lines represent the
mean value. Whiskers denote the standard deviation (SD). The dotted line gives the detection limit for the virus titration. Letters denote
significant statistical differences (P < 0.05) between viral strains (a: 13V091 and 13V117, b: 13V091 and 07V063, c: 13V117 and 07V063).
Figure 6 Antibody response, IPMA (A) and SN (B) in pigs inoculated with PRRSV 13V091, 13V117 and 07V063. Whiskers denote the
standard deviation (SD). Dotted lines denote detection limits. Letters denote significant statistical differences (P < 0.05) between viral strains (a:
13V091 and 13V117, b: 13V091 and 07V063, c: 13V117 and 07V063).
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13V091 group showed the highest titers (2.5 ± 0.6 log10
TCID50/g) of the PRRSV-infected groups (P > 0.05).
Immunofluorescence
Respiratory tract
Double IF stainings were performed for the quantifica-
tion and identification of PRRSV cells. In conchae,
13V091 showed higher amounts of PRRSV+ cells/mm2
(8.0 ± 1.4) compared to 13V117 (2.5 ± 0.7) and 07V063
(4.3 ± 0.7) (Figure 7B). Tissues from the septum dis-
played also a higher amount of PRRSV+ cells/mm2 in
the 13V091 (2.2 ± 1.4) group, compared to the 13V117
(0.8 ± 0.9) and 07V063 (0.6 ± 0.3) groups. In the phar-
ynx, a higher (P < 0.05) number of PRRSV+ cells/mm2
(6.0 ± 1.7) was found with 13V091 than with 13V117
(1.7 ± 1.2) but not from 07V063 (4.3 ± 1.2). Finally, im-
munofluorescence stainings from the left cardiac lobe of
the lung showed higher amounts of PRRSV+ cells/mm2 for
13V091 (25.5 ± 9.1) compared to 13V117 (20.3 ± 5.4) and
07V063 (16.5 ± 2.3). The number of infectious virus parti-
cles per infected cell in the left cardiac lung lobe was calcu-
lated according to the ratio: pfu per gram of tissue/cells
per mm2 after converting TCID50/g to pfu/g [23]. 07V063
showed the highest number (21 200) of infectious virus
particles per infected cell compared to 13V091 (15 300)
and 13V117 (8600).
The Sn phenotype of PRRSV+ cells in the nasal mu-
cosa, tonsils and lungs is shown in Figure 8. Identifica-
tion of PRRSV+ cells in the nasal mucosa based on Sn,
revealed that the 13V091 and 13V117 strains were able
to replicate more efficiently in Sn− cells compared to the
07V063 strain. In conchae, 87.5% of 13V091-infected
cells were Sn−, while that percentage was 80.0% with
the 13V117 and only 17% with the 07V063 strain
(Figure 7B). In the septum, half (48%) of the 13V091-
infected cells and the few 13V117-infected cells (0.8 ±
0.9/mm2) were Sn−, whereas all 07V063-infected cells
were Sn+. In the pharynx and lungs, all isolates showed
Figure 7 Virus titers (A and C), and quantification and identification of PRRSV-infected cells (B and D). Different parts of the respiratory
system and lymphoid tissues from animals inoculated with PRRSV 13V091, 13V117 and 07V063, and euthanized at 10 dpi were analyzed. Dark
colors represent PRRSV+ cells, whereas lighter colors in the subcolumns represent PRRSV+Sn+ cells. CaL denotes the cardiac left part of the lungs.
Whiskers denote the standard deviation (SD) and asteriscs (*) represent statistically significant comparisons (*P < 0.05, **P < 0.01, ***P < 0.001).
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a restricted cell tropism, as the percentage of PRRSV+Sn+
cells ranged from 80.7% to 100% (Figure 7B).
Lymphoid tissues
In tonsils, a higher amount of PRRSV+ cells/mm2 was
found in 13V091-infected tissues (14.0 ± 5.6), compared
to 13V117 (12.5 ± 2.1) and 07V063 (9.0 ± 5.7) -infected
tissues (Figure 7D). In BLN, a higher amount of PRRSV+
cells/mm2 was observed in the 07V063 group (5.5 ± 2.2)
than in the 13V091 (2.6 ± 0.8) and 13V117 (1.5 ± 0.7)
groups, whereas in RPLN, 10.0 ± 2.8 (13V091), 2.5 ± 0.6
(13V117) and 4.5 ± 3.5 (07V063) PRRSV+ cells/mm2
were found. Finally, in MLN, infection with the 13V091
and 07V063 strains resulted in 3.4 ± 1.5 and 3.3 ± 2.3
PRRSV+ cells/mm2 respectively, while infection with the
13V117 strain gave only 1.1 ± 0.8 PRRSV+ cells/mm2. The
amount of PRRSV+ cells in ILN was higher (P < 0.05) with
the 13V091 strain (10.3 ± 0.5) compared to the 13V117
(3.3 ± 2.1) and 07V063 (5.3 ± 0.6) strains. In spleen, the
highest amount of PRRSV+ cells/mm2 was displayed by
13V091 (9.3 ± 6.7) while 13V117 showed 4.3 ± 3.5 and
07V063 4.0 ± 2.8 PRRSV+ cells/mm2.
The highest percentage of infected cells that were Sn−,
ranged from 45% to 64% in tonsils, 20% to 68% in the
different lymph nodes and 64% to 71% in the spleen.
PRRSV genome sequencing and phylogenetic analysis
The full genomes of 13V091 and 13V117 were 15020
and 15014 nucleotides (nt) long (excluding the polyA tail),
respectively. A NCBI BLASTn search showed that the two
viruses belong to the PRRSV type 1 genotype. Pairwise nu-
cleotide comparisons of the complete genomes showed
that 13V117 shared 91.55% identity to Lelystad virus and
99.81% identity to 07V063, whereas 13V091 only shared
86.69% identity to the Lelystad virus and 85.03% to the
07V063 strain. The nucleotide (nt) similarity between
13V091 and 13V117 was 84.38%. 13V091, 13V117 and
07V063 showed deletions in ORF1a, in the region encod-
ing the non-structural protein 2 (nsp2). 13V117 had a
84 nt deletion following the nucleotide position 2345 in
Figure 8 Confocal microscope double immunofluorescence images of 13V091-infected nasal mucosa, tonsils and lungs are illustrated.
Tissue samples were sectioned (9 μm) and co-immunostained for Sn (green) and PRRSV N-protein (red) at 10 dpi. White arrows show PRRSV+Sn+
and PRRSV+Sn− cells. Scale bar 50 μm.
Frydas et al. Veterinary Research  (2015) 46:37 Page 10 of 17
LV. 13V091 had three discontinuous deletions of 3, 45,
and 27 nucleotides following the nt positions 1919, 2384,
and 2492 in LV, respectively. The first deletion of 3 nt has
also been found in five strains isolated in Asia (GenBank:
FJ349261, KF287128-31). The deletions of 45 and 27 nu-
cleotides were located in the highly variable region of nsp2
close to the deletion seen in 13V117. A partial amino acid
alignment representing the highly variable region of nsp2
is shown in Additional file 3. The 13V091 strain, also har-
bored a 3 nt deletion in the region of the genome encod-
ing the structural proteins. This deletion affected both
ORF3 and ORF4 as the coding regions of these two genes
overlap, but did not disturb the open reading frame [24].
Phylogenetic analysis of the complete genomes of the
two viruses to 33 published PRRSV type 1 sequences
showed that 13V091 grouped alone, and 13V117 grouped
with 07V063 (Figure 9). Phylogenetic analysis of 171
complete PRRSV type 1 ORF5 sequences showed that
13V117 grouped with 07V063 and with viruses isolated in
Denmark, China, Korea, and Spain, whereas 13V091
grouped with viruses isolated in Romania. The phylogen-
etic analysis of ORF5 is presented in Additional file 4. The
phylogenetic tree of ORF7 was constructed from 154 se-
quences and showed 13V117 to group with 07V063 and vi-
ruses from Hong Kong, Korea, and Thailand. 13V091
grouped with an Italian isolated virus.
To investigate the impact of the high genetic diversity
of 13V091 and 13V117, a pairwise amino acid compari-
son of the case viruses to three other type 1 viruses was
performed and is shown in Additional file 5. From the
comparison, it was clear that both 13V091 and 13V117
showed a high level of diversity on the protein level to
the LV virus, the subtype 1 prototype and to Lena, the
subtype 3 prototype virus. 13V091 was also different
from 13V117 and 07V063, where the percentage iden-
tity for nsp2, GP3, GP4 and GP5 ranged from 77% to
88%. Finally, full-genome analysis revealed that 13V117
and 07V063 only differed by 8 amino acids located in
nsp1, nsp2, nsp7 nsp9, GP3 and GP4, respectively.
Discussion
PRRSV is one of the most economically important patho-
gens in swine industry worldwide [2]. The virus continues
to evolve genetically and antigenically despite the efforts
for control and eradication [7]. Genetically, PRRSV strains
are divided into European type 1 and North-American
type 2 strains [8]. Type 1 strains are subdivided in four
subtypes (1, 2, 3 and 4). In the recent past, highly patho-
genic type 1 subtype 3 strains emerged in Eastern Europe
but there was no indication of an invasion of these
strains in Western Europe, a region that is dominated
by type 1 subtype 1 isolates [4]. Up till now, no highly
pathogenic type 1 subtype 1 strains have been isolated.
Continuous monitoring of emerging PRRSV isolates is
of great importance in order to prevent new outbreaks
and provide novel insights for vaccine development. In
the current study, the pathogenicity and the virulence
of two new Belgian PRRSV isolates designated 13V091
and 13V117 originating from animals experiencing se-
vere respiratory disorders were compared clinically,
virologically and genetically with the mild-pathogenic
PRRSV strain 07V063.
PRRSV 13V091 appeared to be more pathogenic than
the 13V117 and 07V063 strains. Animals infected with
13V091 showed the longest duration of fever (5.1 ± 4.2)
and the highest clinical scores (1.6 ± 0.3) due to dyspnea,
tachypnea and respiratory distress. Macroscopic analysis
of lungs of pigs euthanized at 10 dpi showed that 13V091
strain caused the most severe multifocal gross lesions
compared to the 13V117 and 07V063 isolates. Percent-
age of lung lesions of 13V091 was also higher than that of
the type 1 strains that were used in a recent study from
Spain [25]. In another Korean study, three new subtype 1
strains were compared with the prototype LV, and it was
found that at 10 dpi only one of them (SNUVR100744,
GenBank: JX988618) showed a higher percentage (>25%)
of affected lung surface than 13V091 (12.9 ± 3.6) [26]. The
clinical and pathological outcome of 13V091 showed
some similarities with the highly pathogenic subtype 3
strain (Lena, GenBank: JF802085) [12,14]. In the latter
study, Lena showed clinical score values ranging from 0.5
to 2 from 3 to 14 dpi, whereas in our results 13V091
showed a clinical score from 0.6 to 1.6 during the same
timeframe. Previous in vivo studies with the Lena strain,
induced fever from 2 till 13 dpi [14], and from 2 till 28 dpi
[12]. In the current study, 13V091 induced fever from 2
till 14 dpi.
The clinical outcome can be fully attributed to PRRSV
and not to PRRSV-related pathogens (SIV, PCV2). Experi-
ments were performed in BSL-2 facilities and pathogenic
bacteria were not isolated from all the euthanized pigs.
Furthermore, no Mycoplasma-related lung lesions were
observed in all animals. Co-infections are important be-
cause they enhance the impact of PRRSV leading to
porcine respiratory disease complex (PRDC) [27]. In a
previous study with highly pathogenic PRRSV strains
that showed mortality, bacteria like Arcanobacterium
pyogenes and Streptococcus suis were isolated from the
lungs [12].
Transmission of PRRSV via airborne route is an im-
portant characteristic after the appearance of highly
pathogenic viral strains [28]. In a previous study, virus
titers in nasal secretions of a highly pathogenic strain
(Lena) showed a titer of 2.5 to 5.6 log10TCID50/100 mg
from 3 to 14 dpi [12]. In the current study, during the
same timeframe, viral titers of 2.0 to 4.8 and 1.8 to 4.3
log10TCID50/100 mg were detected for 13V091 and
13V117 respectively. These results indicate that both
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Figure 9 Phylogenetic analysis of complete genome nucleotide sequences of PRRSV type 1 is presented. The tree was constructed by the
Neighbor Joining algorithm with Bootstrap 1000 replicates. Bootstrap values are shown in percent. 13V091 and 13V117 are highlighted in red.
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new strains although not as pathogenic as Lena, have
the potential to be transmitted via airborne route in the
early stages of infection based on the high virus titers in
the nasal secretions. It has been speculated, that recent
outbreaks in the USA and China were due to virus iso-
lates that can replicate and spread more efficiently [29].
The location of virus replication and an expanded cell
tropism may strongly support this hypothesis. In typical
swine herds, animals are in close nose-to-nose contact
with each other, and during the last years several studies
were performed evaluating the efficiency of different iso-
lates to spread via airborne route [30]. A PRRSV strain
that is able to replicate in the nasal mucosa and produce
progeny virus, will be more likely to spread to another
pig via airborne route compared to a virus strain that
mainly replicates the lungs such as typical LV-like
strains. In addition, presence of other nose pathogens
such as Bordetella bronchiseptica and Chlamydia suis
may cause intensive sneezing, which may facilitate virus
spread [31].
In this study, different PRRSV strains showed a differ-
ent tissue tropism. Animals infected with the 13V091
strain, showed the highest replication efficiency based
on virus titration and PRRSV-positive cell counting.
Furthermore, 13V091 showed significantly higher numbers
of PRRSV+ cells compared to 13V117 and 07V063 in the
upper respiratory tract, tonsils and draining lymph nodes
(conchae, septum, pharynx, RPLN). Respective virus titers
of 13V091 were 10 to 1000 times higher than 13V117, and
10 times higher than 07V063. In the upper respiratory
tract, 13V091 and 13V117 showed an expanded cell trop-
ism as they were shown to replicate in Sn− macrophages
with a different degree of efficiency. It is important to men-
tion that in the nasal mucosa (conchae, septum), the same
distribution pattern of PRRSV+Sn− cells was observed for
13V091 and 13V117, with cells being located within the
epithelium, and just underneath the basement membrane.
Large round cells with large cytoplasm was the morphology
of PRRSV+Sn− and PRRSV+Sn+ cells located in the lamina
propria, whereas PRRSV+Sn− cells located within the epi-
thelium and just underneath the basement membrane were
smaller with large elongated filopodia. Together with the
disability of Lelystad virus to grow in Sn− cells and the
strong ability of a highly pathogenic PRRSV strain (Lena) to
replicate extremely efficiently in Sn− cells of the nasal mu-
cosa, this indicates that in Western Europe there is an in-
crease of PRRSV tropism for Sn− nasal macrophages in
time, which reaches the level of virulent/pathogenic sub-
type 3 strains [32].
In our study, 13V091 showed a higher replication rate
and produced more progeny virus in the lungs compared
to 13V117 and 07V063. Viral loads of type 1 subtype 1
strains of our study in lungs, are in agreement with the
results of Labarque et al., where LV reached a mean titer
of 106.2 TCID50/g in lung tissues at 9 dpi [10]. It was
shown before, that PRRSV replication in the lungs is
correlated with the number of the susceptible Sn+ macro-
phages that are present at the time of infection and that
only 2% of susceptible macrophages are infected [10]. In
the present study, 13V117 and 07V063 showed a similar
number of viral antigen positive cells and virus titers
in the left cardiac lung lobe (13V117: 20.3 cells/mm2 and
105.4 TCID50/g, 07V063: 16.5 cells/mm
2 and 105.7
TCID50/g). Analysis of the virus production per infected
cell showed that 13V091 and 07V063 were able to pro-
duce more infectious virus particles per infected cell than
13V117 in a ratio of 1:2 and 1:2.4 respectively. Thus, not
only the number of susceptible cells, but also the strain-
dependent replication efficiency is important for PRRSV
lung pathogenesis. Differences in replication level within
distinct lung lobes were not observed with all the tested
strains, which correlate with two other studies with the
Lelystad (LV) virus, where no difference in replication
levels of distinct lung lobes was observed at 10 dpi [10,18].
Virus replication in BLN and MLN showed that 13V091
and 07V063 produced similar amounts of virus, which
were up to 1000 times higher than 13V117. High viral
loads of 13V091 and 07V063 in the lungs and the draining
lymph nodes (BLN, MLN) can be explained by the
mobilization of Sn+ cells from lungs to LN. In addition,
strains with an expanded cell tropism like 13V091, may
use the Sn− monocytic cells that are infiltrating after 9 dpi
to increase their transportation and replication efficiency
in the correspondent tissues [10].
In the spleen, 13V091 showed the highest replication
level compared to the other tested isolates and the virus
production reached 102.8 TCID50/g at 10 dpi, which was
similar to LV (103 TCID50/g) at 8 dpi [33]. More than
60% of PRRSV-infected cells were of Sn− phenotype.
The lower replication level observed in spleen compared
to lungs and lymph nodes might be explained by the low
expression of Sn and presence of other receptor(s). In
rats, it was shown that Sn expression on splenic macro-
phages is reduced 25-fold compared to lymph node mac-
rophages mainly due to masking of Sn by endogenous
ligands [34].
In our study, PRRSV-specific antibodies for all strains
appeared at 7 dpi and reached a plateau at 14 dpi, which
is in agreement with previous studies using other PRRSV
strains [10,35]. The late induction and the low titers of
neutralizing antibodies observed in the current study is
in agreement with other studies that used the LV and
the 07V063 strains, where only low titers of Nabs were
observed after 25 dpi for LV (21–3.6), and after 35 dpi for
07V063 (21–2.2) [10,16]. A correlation between the ap-
pearance of neutralizing antibodies (Nabs) and the virus
elimination from blood was mentioned before, but the
exact degree of Nabs contribution in viral clearance is
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still questionable [35-37]. Only in the 07V063 group
Nabs appeared at the same time with the elimination of
viremia, an observation that was reported before for the
07V063 strain [16]. In 13V091 and 13V117, Nabs ap-
peared later and at lower titers, and at that time the
virus was already eliminated from blood. Based on these
observations, it is obvious that neutralizing antibodies
are not the sole immunological tool to eliminate PRRSV,
and their role in clearance of primary viremia and pre-
vention of reinfection is not clear [38]. The presence of
additional glycosylation sites at the neutralizing epitopes,
and the sensitivity of the SN test, might contribute for
the late development of Nabs observed in 13V091 and
13V117 compared to 07V063. Analysis of glycosylation
sites on PRRSV structural proteins based on Lelystad
virus, revealed one additional glycosylation site for
13V091 into GP3 protein at the amino acid position
253 [39]. No additional or different glycosylation sites
were observed within 13V117 and 07V063. Addition of
newly acquired sugar moieties to the sugar tree of
13V117 may make the virus unrecognizable and mask
the neutralizing epitopes that reduce or eliminate the
binding affinity of the antibodies. This mechanism of im-
mune evasion has been well described for HIV-1 [40].
MARC-145 cells and PRRSV strains adapted on this cell
line are generally used in SN tests. This cell type is not
the natural cell-target for PPRSV and does not express
Sn, and CD163 is not present at detectable levels. Both
Sn and CD163 are main factors for PRRSV entry and
replicaton, and are major targets for viral entry media-
tors (GP5-M for Sn and GP2-GP3-GP4 for CD163)
[41,42]. Therefore, primary target cells like alveolar mac-
rophages or cell lines that express Sn and CD163 like
PK15Sn-CD163 cells should be preferably used for all the
contemporary PRRSV strains that have a main tropism
for PAM [43]. Newly emerging isolates with a tropism
for additional receptors might need another SN test
based on primary monocytic cells from nasal mucosa or
lymph nodes that express the new receptors to search
for neutralizing antibodies. New SN tests might help to
better understand the function of virus Nabs, with re-
gard to the degree of viral clearance.
To study the evolutionary relationship of 13V091 and
13V117 with other PRRSV strains, the complete genome
sequence was compared with other type 1 European
strains and the prototype type 2 strain VR-2332. 13V091
showed a high genetic diversity to all, currently, publicly
available complete genomes of type 1 viruses and was lo-
cated “alone” in the phylogenetic tree between 13V117
and 07V063, and the highly pathogenic subtype 3 strain
Lena. The phylogenetic analysis of ORF5 and ORF7
showed that 13V091 and 13V117 grouped with other type
1 subtype 1 sequences, thus, it can be concluded that both
isolates belong to PRRSV type 1 subtype 1.
By coincidence, 13V117 showed an extremely high
genetic similarity to 07V063. Despite the fact that gen-
ome comparison revealed only eight different amino
acids, the virological, clinical and pathological changes
induced by these two viruses were quite different.
13V117 replicated efficiently in the nasal mucosa, in-
duced a high viremia but had problems to replicate in
lymphoid tissues. In addition, 13V117-infected animals
showed breathing problems between 2 and 7 dpi. On the
other hand, animals from the 07V063 group, showed a
restricted replication in the nasal mucosa, a ten-fold
lower viremia but an extensive replication in the lymph-
oid tissues. Only two pigs had mild breathing problems.
Pairwise alignments revealed that the following eight
amino acid differences were observed between 07V063
and 13V117: V140M in nsp1, H786L and G1300S in
nsp2, S2192N in nsp7a, M72I and M266V in nsp9,
N253H in GP3 and Q72P in GP4. Nsp1 is a cysteine
protease that plays an important role in the cleavage of
ORF1 proteins and for virion biogenesis [44]. Nsp2 is
the papain-like proteinase 2 (PLP2) that is encoded from
ORF1a and is responsible for the cleavage of the nsp2-3
junction [7]. It is the most variable non-structural protein
between PRRSV subtypes, and it contains a hypervariable
region (HVR) in which deletions are commonly found
among PPRSV isolates; a cluster of immunodominant
B- and T-cell epitopes was also identified [7]. Deletions in
nsp2 have also been found for 13V091 and 13V117. Re-
cent data support the hypothesis that these deletions are
not necessarily related to virulence, but other studies sup-
port that changes in the nsp2 region might be related with
plaque appearance and the cytolytic activity of the isolate
[45,46]. Nsp7a is a 149 aa protein that plays an important
role in the induction of host humoral immune response
and has been found to induce specific antibodies as early
as 14 dpi till 202 dpi [47]. Nsp9 is the RNA-dependent
RNA polymerase (RdRp) encoded by ORF1b. It mediates
the genome replication and the synthesis of subgenomic
mRNAs, and is one of the most conserved proteins within
nidoviruses [7]. GP3 is a heavily glycosylated membrane
protein with a hydrophobic C-terminal domain [39]. The
single amino-acid change in GP3 between 07V063 and
13V117 is located within the neutralizing antigenic region
in the C-terminal domain, that has been found to be
recognised by neutralizing antibodies against LV [39]. GP4
is a membrane protein with an N-glycosylated ectodomain
that forms a heterotrimer with GP2 and GP3, and inter-
acts with GP5 [42]. The single amino acid difference be-
tween 07V063 and 13V117 is located at the ectodomain
of GP4 within the most immunogenic region that was
identified, in all envelope proteins, but is also part of a
neutralizing antibody region (NAR) named ES12 found to
induce high virus neutralizing antibody titers at 42 dpi in
all the 6 tested animals of the study [42,48]. In our results,
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only one animal in the 13V117 group showed low virus
neutralizing antibody titers at 42 dpi, whereas at the same
timepoint all animals in the 07V063 group developed
virus neutralizing antibody titers (mean titer: 22.16).
Whether these single amino acid substitutions have an ef-
fect on virus pathogenesis and immune response by chan-
ging the glycan shielding, or the possible immune decoy
epitopes remains to be clarified. A distinct PRRSV popula-
tion was reported that emerged by one single amino acid
change in the GP5 ectodomain after infection in pigs [49].
Furthermore, it was reported for lactate dehydrogenase
virus (LDV) in mice that a small number of mutations in
ORF5 can alter the tropism and the interaction of virus
with neutralizing antibodies favoring viral persistence [50].
Viral persistence may also be favored by a single amino
acid change in the C-terminus region of a viral protein if
this modification, creates a novel motif selecting the re-
tainment of virions to the endoplasmatic reticulum (ER)
[49]. Production of viral infectious clones of the 07V063
and 13V117 isolates and site-directed mutations will shed
new light in this field.
In summary: (1) two new PRRSV strains designated
13V091 and 13V117 were isolated from pigs showing re-
spiratory distress. Pathogenic and genetic studies showed
that 13V091 is the most pathogenic type 1 subtype 1
strain isolated up till now showing fever, breathing prob-
lems, high virus titers in nasal secretions, an increased
percentage of lung lesions in young animals and an ex-
panded cell tropism to Sn− cells in nasal mucosa and other
lymphoid tissues. (2) Despite the fact that 13V117 and
07V063 have only eight amino acid differences in their
genomes, they showed contrasting clinical and virological
outcomes. 13V117 was able to induce fever, high viremia,
and respiratory problems at the early stages of infection
and it was able to replicate in the nasal mucosa but not in
the lymph nodes, whereas 07V063 showed only fever, a
10-fold lower viremia, low virus titers in nasal excretions,
but higher virus titers in lymphoid tissues.
These are important findings in order to evaluate the
virulence and the pathogenesis caused by different type 1
subtype 1 PRRSV strains, to control the respiratory disease
caused by PRRSV in young animals, and to develop novel
vaccines for the newly emerged PRRSV isolates.
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